» Go to news main
Just published! Intra‑individual comparison of 18F‑sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC‑A1): a multicentre, phase 3 trial
Congratulations to Dr. Steven Burrell on his latest published article!
Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial
François Bénard, Sara Harsini, Don Wilson, Katherine Zukotynski, Gad Abikhzer, Eric Turcotte, Mariève Cossette, Ur Metser, Jonathan Romsa, Montgomery Martin, Colin Mar, Fred Saad, Jean-Paul Soucy, Bernhard J Eigl, Peter Black, Andra Krauze, Steven Burrell, Alan Nichol, Jean-Claude Tardif
The Lancet Oncology Volume 23, Issue 12, December 2022, Pages 1499-1507
Detection of skeletal metastases in patients with prostate cancer or breast cancer remains a major clinical challenge. We aimed to compare the diagnostic performance of 99mTc-methylene diphosphonate (99mTc-MDP) single-photon emission CT (SPECT) and 18F-sodium fluoride (18F-NaF) PET–CT for the detection of osseous metastases in patients with high-risk prostate or breast cancer.
- Congratulations to the 2023 David Fraser Radiology Research Foundation Summer Studentship recipients!
- Congratulations, Dr. Brewer! The Charles Lo Prize in Radiology Research
- Radiology Research Day
- Congratulations to our Research Day award winners!
- Professor Abdolell at ECR
- Dr. Manos presents at ECR
- Faculty presents at ECR
- Dr. Ahmad at ASPNR
comments powered by Disqus